$937.00
Enzyme Immuno-assay designed for measuring heparin-dependent antibodies. This assay measures only the IgG isotype associated with heparin.
PRODUCT DESCRIPTION
In EU: This Product is CE Marked. Health Canada Licensed. Enzyme Immuno-assay designed for measuring heparin-dependent antibodies of the IgG isotype, in human plasma or serum, or in any biological fluid where these antibodies must be measured. This assay measures only the IgG isotype, reported as the most associated with the clinical complications of heparin dependent antibodies (HIT/HITT), allowing confirmation of the diagnosis of HIT/HITT or its clinical suspicion. However, some cases associated with only IgM and/or IgA isotypes can be missed.
Enzyme Immuno-assay designed for measuring heparin-dependent antibodies. This assay measures only the IgG isotype associated with heparin.
PRODUCT CHARACTERISTICS
Total Assay Time: 2 hr 15 min
Cut Off: A450 > 0.30
Dynamic Range: A450 up to 3.0
Intra-Assay CV: 4 to 6%
Inter-Assay CV: 5 to 8%
PRODUCT COMPONENTS
Micro ELISA Plate (12 strips of 8 wells)
2x HIA Sample Diluent.
3x HIA IgG Positive Control.
3x Negative Control.
3x Platelet Lysate.
3x Anti-IgG (Fcγ)-HRP IC.
1x Conjugate Diluent.
1x Wash Solution.
1x TMB.
1 x 0.45M Sulfuric Acid.
Video of Product Components
PRODUCT APPLICATION
Clinical suspicion of HIT during heparin therapy.
Heparin-dependent antibodies of the IgG isotype are those strongly associated with the clinical diagnosis of HIT. The ZYMUTESTâ„¢ HIA IgG assay offers then a better specificity for the clinical complication of HIT, but it has less sensitivity as cases associated with only IgM and/or IgA isotypes are missed.
MSDS Documents
IFU Documents
